U.S. Neurovascular Devices Market Revenue & Forecast Analysis, 2026-2035
The U.S. neurovascular devices market was estimated at USD 2.9 billion and is projected to grow at a CAGR of 5.5% from USD 3.01 billion in 2026 to USD 4.9 billion in 2035. The market is undergoing significant expansion, fueled by the growing incidence of neurological conditions and the escalating impact of cerebrovascular illnesses nationwide. Additionally, enhancing investments in stroke care facilities and neurointerventional laboratories, coupled with growing awareness of early detection and treatment, is fostering market expansion.
Market Overview
As per the U.S. National Institute of Neurological Disorders and Stroke (NINDS) and associated clinical stroke registries, ischemic stroke constitutes approximately 87% of stroke incidents in the United States, with an increasing need for minimally invasive endovascular procedures like thrombectomy and neurovascular devices propelling the uptake of sophisticated neurovascular device technologies in the management of acute stroke and treatment of cerebral aneurysms.
The U.S. Neurovascular Devices Market has experienced robust and steady growth in the last ten years, fueled by the rising occurrence of ischemic stroke, increasing rates of intracranial aneurysms, and a growing acceptance of minimally invasive neurointerventional techniques. The market has greatly gained from developments in mechanical thrombectomy devices, flow diverters, and embolic protection systems, which have enhanced treatment results and broadened the qualifying patient demographic. For instance, the extensive use of stent retrievers for managing acute ischemic strokes in hospitals across the U.S. has notably raised procedural volumes in recent years.
The U.S. Neurovascular Devices Market is anticipated to undergo significant growth in the forecast period, driven by the growing elderly population, heightened awareness of prompt stroke treatment, and ongoing technological advancements in neurointerventional devices. For instance, by 2035, the use of advanced neurovascular technologies like AI-driven imaging support, sophisticated aspiration systems, and bioresorbable flow diverters is anticipated to increase notably in major stroke centers throughout the U.S., leading to greater procedural accuracy, fewer complications, and improved survival rates for patients.
U.S. Neurovascular Devices Market Overview
Base Year Market Size (2025): USD 2.9 Billion
CAGR: 5.5%
Forecast Year Market Size (2035): USD 4.9 Billion
Major Players:
Medtronic plc
Stryker Corporation
Johnson & Johnson (DePuy Synthes / Cerenovus)
Penumbra, Inc.
Boston Scientific Corporation
U.S. Neurovascular Devices Market Trends
The U.S. Neurovascular Devices Market is undergoing significant changes, fueled by the growing occurrence of strokes, swift technological advancements, and a heightened use of minimally invasive neurointerventional techniques in extensive stroke care facilities.
A significant trend is the increasing use of mechanical thrombectomy tools, like stent retrievers and aspiration catheters, which are now establishing themselves as the standard treatment for acute ischemic stroke in hospitals across the U.S.
The market is experiencing swift progress in flow diverters and embolic coil techniques, which are being more commonly utilized for addressing complex intracranial aneurysms, enhancing safety and long-term clinical results.
A significant move is occurring towards minimally invasive endovascular techniques, decreasing the necessity for open neurosurgery and allowing quicker recovery times, shorter hospital durations, and reduced procedural risks.
Furthermore, the growing integration of AI-driven imaging and navigation technologies enhances diagnostic precision and procedural accuracy in neurovascular procedures, particularly in stroke assessment and treatment strategy development.
Collectively, technological advancements, increasing stroke incidence, and greater availability of advanced neurointerventional treatments are crucial elements influencing the future development of the U.S. Neurovascular Devices Market.
U.S. Neurovascular Devices Market Analysis
By Product Type
Neurovascular thrombectomy devices dominate the U.S. market due to their critical role in acute ischemic stroke treatment and increasing adoption of mechanical clot removal procedures
Based on product type, the U.S. Neurovascular Devices Market is categorized into neurovascular thrombectomy devices, neurovascular embolization devices, neurovascular stents, and neurovascular balloons. The neurovascular thrombectomy devices segment holds the largest market share of 42.46% in 2025.
By Application
Acute ischemic stroke dominates the U.S. neurovascular devices market due to its high prevalence and urgent need for rapid mechanical intervention to restore cerebral blood flow
Based on application, the U.S. Neurovascular Devices Market is categorized into acute ischemic stroke, hemorrhagic stroke, intracranial aneurysm, arteriovenous malformations (AVMs) & AV fistulas, carotid artery disease, and others. The acute ischemic stroke segment holds the largest market share in 2025.
By End-use
Hospitals dominate the U.S. neurovascular devices market due to high stroke treatment volumes, availability of advanced neurointerventional labs, and 24/7 emergency care infrastructure.
Based on end-use, the U.S. Neurovascular Devices Market is categorized into hospitals, specialty clinics, and others. The hospitals segment holds the largest market share in 2025.
Key Companies Profiled
The U.S. Neurovascular Devices Market is significantly consolidated, dominated by major global medical device companies that together hold a substantial portion of the market. Competition mainly relies on technological advancements, clinical effectiveness, robust product lines, and solid collaborations with hospitals in extensive stroke centers. Key companies like Medtronic plc, Stryker Corporation, Johnson & Johnson (Cerenovus), Penumbra, Inc., and Boston Scientific Corporation lead the market, bolstered by their innovative thrombectomy devices, embolization coils, flow diverters, and neurovascular stenting products. These firms gain from robust R&D skills and ongoing product advancements focused on enhancing stroke treatment results and procedural effectiveness.
The market is also influenced by the rising acceptance of mechanical thrombectomy as a routine treatment for acute ischemic stroke, which has greatly bolstered the standing of major manufacturers. Moreover, increasing investments in stroke care facilities and the growth of comprehensive stroke centers throughout the U.S. are boosting procedural volumes and driving demand for advanced neurovascular devices.
U.S. Neurovascular Devices Market Companies:
Abbott Laboratories
AngioDynamics, Inc.
Balt USA LLC
Boston Scientific Corporation
Cardinal Health
Cook Medical
Johnson & Johnson (Cerenovus)
Medtronic plc
MicroVention, Inc.
Penumbra, Inc.
Phenox GmbH (U.S. operations)
Stryker Corporation
Terumo Corporation (U.S. presence)
Vascular Solutions (Teleflex Incorporated)
Wallaby Medical
W. L. Gore & Associates
Market Segmentation
This study provides revenue growth and emerging trends across global, regional, and country levels from 2021 to 2035, segmenting the U.S. Neurovascular Devices market by-
Product Type (Revenue in USD Million, 2021 - 2035)
Neurovascular Thrombectomy Devices
Stent Retrievers
Aspiration Catheters
Combined Thrombectomy Systems
Rheolytic Devices
Neurovascular Embolization Devices
Embolization Coils
Flow Diversion Devices
Liquid Embolic Agents
Particles & Microspheres
Neurovascular Stents
Carotid Artery Stents
Intracranial Stents
Neurovascular Balloons
Compliant Balloons
Non-Compliant Balloons
Semi-Compliant Balloons
Application (Revenue in USD Million, 2021 - 2035)
Acute Ischemic Stroke
Hemorrhagic Stroke
Intracranial Aneurysm
Arteriovenous Malformations (AVMs) & AV Fistulas
Carotid Artery Disease
Others
End-use (Revenue in USD Million, 2021 – 2035)
Hospitals
Specialty Clinics
Others
Table of Content
1. Methodology and Scope
1.1. Scope of the Study
1.1.1. Market Segmentation
1.1.2. Market Definition
1.1.3. Inclusions and Exclusions of the Study
1.2. Research Design
1.2.1. Base Year, Historical Data, and Forecast Period
1.2.2. Data Collection Methods
1.2.2.1. Secondary Sources
1.2.2.2. Primary Sources
1.2.3. Research Methodology
1.2.3.1. Base Year Calculation/ Parent Market Analysis, Company/ Brand Share Analysis, 2025 (Top-down Approach)
1.2.3.2. Volume-Price Approach (Bottom-up Approach)
1.2.3.3. Data Triangulation
1.2.4. Forecasting Model
1.3. Research Assumptions
1.4. Validation and Data Quality Control
1.5. List of Primary Sources
1.6. List of Secondary Sources
2. Executive Summary
2.1. Market Overview
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
3. Industry Outlook
3.1. Industry Ecosystem Analysis
3.2. Parent/ Ancillary Market Analysis
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Restraints/ Challenges
3.3.3. Opportunities
3.4. Value Chain Analysis
3.5. Technology Roadmap
3.6. Porters Analysis
3.7. PESTLE Analysis
4. Market Estimates and Forecasts, By Product Type, 2021 - 2035 (Market Size in USD Mn)
4.1. Neurovascular Thrombectomy Devices
4.1.1. Stent Retrievers
4.1.2. Aspiration Catheters
4.1.3. Combined Thrombectomy Systems
4.1.4. Rheolytic Devices
4.2. Neurovascular Embolization Devices
4.2.1. Embolization Coils
4.2.2. Flow Diversion Devices
4.2.3. Liquid Embolic Agents
4.2.4. Particles & Microspheres
4.3. Neurovascular Stents
4.3.1. Carotid Artery Stents
4.3.2. Intracranial Stents
4.4. Neurovascular Balloons
4.4.1. Compliant Balloons
4.4.2. Non-Compliant Balloons
4.4.3. Semi-Compliant Balloons
5. Market Estimates and Forecasts, By Application, 2021 – 2035 (USD Mn)
5.1. Acute Ischemic Stroke
5.2. Hemorrhagic Stroke
5.3. Intracranial Aneurysm
5.4. Arteriovenous Malformations (AVMs) & AV Fistulas
5.5. Carotid Artery Disease
5.6. Others
6. Market Estimates and Forecasts, By End-use, 2021 – 2035 (USD Mn)
6.1. Hospitals
6.2. Specialty Clinics
6.3. Others
7. Market Estimates and Forecasts, By U.S., 2021 - 2035 (USD Mn)
7.1.1. U.S.
7.1.1.1. U.S. Neurovascular Devices Market Estimates and Forecasts to 2035 (USD Mn)
7.1.1.2. Market Dynamics
7.1.1.3. Competitive Landscape
7.1.1.4. Regulatory Framework
7.1.1.5. Reimbursement Scenario
8. Competitive Landscape
8.1. Company Market Share Analysis, 2025
8.2. Company Tier Structure
8.3. List of Major Suppliers, By Key Countries
8.4. Key Company Positioning Analysis
8.5. Company Profile
8.5.1. Abbott Laboratories
8.5.2. AngioDynamics, Inc.
8.5.3. Balt USA LLC
8.5.4. Boston Scientific Corporation
8.5.5. Cardinal Health
8.5.6. Cook Medical
8.5.7. Johnson & Johnson (Cerenovus)
8.5.8. Medtronic plc
8.5.9. MicroVention, Inc.
8.5.10. Penumbra, Inc.
8.5.11. Phenox GmbH (U.S. operations)
8.5.12. Stryker Corporation
8.5.13. Terumo Corporation (U.S. presence)
8.5.14. Vascular Solutions (Teleflex Incorporated)
8.5.15. Wallaby Medical
8.5.16. W. L. Gore & Associates
9. Analyst Perspective
10. Related Reports
Related Research
Revolution Insights Briefs
Stay informed with updates on related market reports and key industry topics.